HEPPI: Efficacy of a Cognitive-Emotional Intervention for Homebound Older Adults
NCT ID: NCT05499767
Last Updated: 2023-05-09
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
199 participants
INTERVENTIONAL
2021-09-01
2023-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
A two-arm randomized controlled trial (RCT) is conducted to investigate the efficacy of the HEPPI among the homebound older population.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Homebound Elderly People Psychotherapeutic Intervention
NCT04967378
Applying a Person-Centered Approach to Enhance Cognitive Training in Senior Living Community Residents With Mild Cognitive Impairment
NCT03292705
Psychological Treatment to Support the Consequences of Cognitive Impairment
NCT04356924
Long-Covid: Treatment of Cognitive Difficulties
NCT05167266
Making Memory Better for Seniors With Mild Cognitive Impairment
NCT01532739
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The research design of the trial followed the methodological recommendations for conducting goropsychoterapy research. Moreover, a pilot RCT was conducted prior to the present RCT, in order to assess the feasibility, acceptability, and preliminary efficacy of the HEPPI. Appropriate adjustments to the HEPPI protocol were carried out considering the results.
The present study is a two-arm RCT comparing the intervention condition (HEPPI) to a treatment as usual (TAU) control group. The sample includes community-dwelling older adults who do not leave home more often than once a week. Homebound older adults are recruited from the community through contact with their health care networks. A minimum number of 79 participants per condition will be required (N=158). Accounting for an expected 20% attrition rate, an anticipated sample of 198 participants will be enrolled in the study. Participants who demonstrate interest in the study are informed of the goals and procedures of the research and asked to provide informed consent before eligibility assessment. Eligible participants are randomly assigned to the HEPPI or the TAU group.
Homebound older adults are asked to complete baseline, post-intervention, and 3-month follow-up assessments. Assessments include neuropsychological tests to assess cognition function, psychological health, subjective memory complaints, quality of life, functional status, perceived loneliness, and personality. The study procedures take place at the participants' homes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
SUPPORTIVE_CARE
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
HEPPI
The HEPPI group attends weekly 90-minute intervention sessions at the participants' homes.
HEPPI
Homebound Elderly People Psychotherapeutic Intervention
Treatment as Usual (TAU)
The TAU group receives access to HEPPI at the end of the study.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
HEPPI
Homebound Elderly People Psychotherapeutic Intervention
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* MoCA score 1 to 1.5 standard deviation below the mean for age- and education- adjusted norms;
* FCSRT total immediate and delayed recall scores ≤ 35 and ≤ 12, respectively;
* Presence of subjective memory complaints (SMCS score ≥ 3);
* Presence of depressive symptomatology (GDS-30 score ≥ 11);
* Presence of anxious symptomatology (GAI score ≥ 8);
* No significant impact from cognitive impairment on daily functional capacity;
* Residence in mainland Portugal;
Exclusion Criteria
* Presence of severe psychiatric illnesses;
* Presence of comorbid medical conditions associated with cognition decline;
* Use of psychotropic medication for less than three months;
* Presence of alcoholism or toxicomania;
* Significant impairment of vision, hearing, communication, or manual dexterity.
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Foundation for Science and Technology, Portugal
OTHER
University of Coimbra
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andreia Jesus
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Center for Research in Neuropsychology and Cognitive Behavioral Intervention (CINEICC)
Coimbra, , Portugal
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Jesus AG, de Lima MP, Vilar M, Pachana NA. Homebound elderly people psychotherapeutic intervention (HEPPI): Exploring the mediating role of loneliness. Arch Gerontol Geriatr. 2024 Mar;118:105308. doi: 10.1016/j.archger.2023.105308. Epub 2023 Dec 3.
Jesus AG, Lima MP, Vilar M, Pachana NA. HEPPI: a randomized controlled trial of the efficacy of a cognitive-emotional intervention for homebound older adults. Aging Ment Health. 2024 Mar-Apr;28(3):491-501. doi: 10.1080/13607863.2023.2260760. Epub 2023 Sep 25.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SFRH/BD/146170/2019
Identifier Type: OTHER_GRANT
Identifier Source: secondary_id
HEPPIEfficacy/CINEICC
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.